EpicentRx has assembled a world-class scientific advisory board that includes renowned scientists and clinicians from such institutions as Johns Hopkins University, Stanford University, the Institute for Advanced Study at Princeton University, Children’s Hospital Research Institute in Oakland (CHORI), Dana Farber and the University of California at San Francisco and San Diego (UCSF and UCSD). We leverage the know-how and expertise of our collaborators in epigenetics, oncology and radiation oncology, immunology, and free radical, vascular and red blood cell biology to expand the EpicentRx pipeline through development of truly innovative medicines with unique epigenetic-based modes of action.